Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong
Background Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. Methods Based on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. Results In this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. Conclusion The target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Chinese medicine - 15(2020), 1 vom: 03. Nov. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhong, Linda L. D. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Acupuncture |
|---|
| doi: |
10.1186/s13020-020-00397-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR04179169X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR04179169X | ||
| 003 | DE-627 | ||
| 005 | 20230519184141.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201105s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s13020-020-00397-9 |2 doi | |
| 035 | |a (DE-627)SPR04179169X | ||
| 035 | |a (SPR)s13020-020-00397-9-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 100 | 1 | |a Zhong, Linda L. D. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. Methods Based on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. Results In this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. Conclusion The target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong. | ||
| 650 | 4 | |a Chinese medicine |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Clinical practice guideline |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Stroke |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Acupuncture |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Evidence-based medicine |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Kun, Wai |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Nannan |e verfasserin |4 aut | |
| 700 | 1 | |a Ziea, Tat Chi |e verfasserin |4 aut | |
| 700 | 1 | |a Ng, Bacon F. L. |e verfasserin |4 aut | |
| 700 | 1 | |a Gao, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Bian, Zhaoxiang |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Aiping |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chinese medicine |d London : BioMed Central, 2006 |g 15(2020), 1 vom: 03. Nov. |w (DE-627)SPR029471745 |w (DE-600)2260322-0 |x 1749-8546 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2020 |g number:1 |g day:03 |g month:11 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1186/s13020-020-00397-9 |z kostenfrei |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2020 |e 1 |b 03 |c 11 | ||